CINDY CUNNINGHAM: Open Payments
NPI 1447277207 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,489 in 149 payments from 16 companies in 2025. Trend: 2023 $3,697 · 2024 $3,661 · 2025 $3,489
Food & beverage: $3,366Education: $123
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $586 |
| Alkermes, Inc. | 23 | $544 |
| Neurocrine BioSciences, Inc. | 15 | $375 |
| Teva Pharmaceuticals USA, Inc. | 16 | $356 |
| Lundbeck LLC | 20 | $350 |
| Axsome Therapeutics, Inc. | 8 | $327 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $270 |
| ABBVIE INC. | 16 | $187 |
| Vanda Pharmaceuticals Inc. | 8 | $152 |
| Janssen Pharmaceuticals, Inc | 5 | $120 |
Products named: REXULTI, INGREZZA, Auvelity, CAPLYTA, ARISTADA, LYBALVI, ABILIFY MAINTENA, VRAYLAR.
Industry payments across DE — which companies pay providers there.
